A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Related studies linked through entity extraction aliases.